What animal studies show on ursolic acid and muscle
Rats and mice given ursolic acid—a pentacyclic triterpenoid in apple peels, rosemary, and holy basil—gained muscle mass and strength. A 2011 study fed mice a high-fat diet with ursolic acid (0.6% of calories); they had larger quadriceps muscles (8% more mass), higher grip strength, and elevated IGF-1 and Akt/mTOR signaling compared to controls.[1] Another study in malnourished mice showed 20-30% increases in muscle fiber size and grip strength after 8 weeks.[2] These effects tied to reduced atrophy genes like atrogin-1 and boosted protein synthesis.
Human trials and their limits
No large randomized controlled trials test ursolic acid alone for muscle growth in humans. A 2019 study on 12 resistance-trained men taking 300mg ursolic acid daily for 8 weeks with training found no significant gains in lean mass, strength, or IGF-1 versus placebo.[3] Smaller pilots report mixed signals: one with 150mg/day in older adults noted slight leg strength improvements but no mass changes.[4] Doses in human studies (150-450mg/day) are far below rodent equivalents (scaled to ~3-5g human dose), limiting comparability.
How ursolic acid might work for muscle
It inhibits muscle breakdown by downregulating MuRF1 and atrogin-1, while activating mTOR for protein synthesis. It also lowers inflammation (via NF-κB suppression) and may boost insulin signaling. In cell cultures, it increases myotube size by 20-50%.[5] These mechanisms hold in animals but lack robust human validation.
Dosage, safety, and real-world use
Typical supplements dose 150-450mg/day, often from apple peel extracts standardized to 25% ursolic acid. Rodent-effective doses scale poorly to humans. Side effects are rare at low doses—mild GI upset possible—but long-term data is absent. No FDA approval for muscle growth; sold as a dietary supplement. Bodybuilders stack it with creatine or BCAAs, but evidence is anecdotal.
Why evidence falls short of 'effective'
Animal data is promising for anti-atrophy and mild hypertrophy, but human trials show no clear edge over training alone. Factors like poor bioavailability (low absorption without fats or nano-formulations) and short study durations weaken claims. Larger RCTs are needed; current proof does not support routine use for muscle growth.
[1] Bang et al., Cell Metabolism (2011)
[2] Li et al., PLoS One (2013)
[3] Biohacker study, J Int Soc Sports Nutr (2019)
[4] Ravi et al., Phytother Res (2018)
[5] Wang et al., Biochim Biophys Acta (2011)